A three pulse phase response curve to three milligrams of melatonin in humans.

A three pulse phase response curve to three milligrams of melatonin in humans. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

A three pulse phase response curve to three milligrams of melatonin in humans. Abstract Text:

Helen J Burgess,Victoria L Revell,Charmane I Eastman,Helen J Burgess,Victoria L Revell,Charmane I Eastman,

Exogenous melatonin is increasingly used for its phase shifting and soporific effects. We generated a three pulse phase response curve (PRC) to exogenous melatonin (3 mg) by administering it to free-running subjects. Young healthy subjects (n = 27) participated in two 5 day laboratory sessions, each preceded by at least a week of habitual, but fixed sleep. Each 5 day laboratory session started and ended with a phase assessment to measure the circadian rhythm of endogenous melatonin in dim light using 30 min saliva samples. In between were three days in an ultradian dim light (< 150 lux)-dark cycle (LD 2.5 : 1.5) during which each subject took one pill per day at the same clock time (3 mg melatonin or placebo, double blind, counterbalanced). Each individual's phase shift to exogenous melatonin was corrected by subtracting their phase shift to placebo (a free-run). The resulting PRC has a phase advance portion peaking about 5 h before the dim light melatonin onset, in the afternoon. The phase delay portion peaks about 11 h after the dim light melatonin onset, shortly after the usual time of morning awakening. A dead zone of minimal phase shifts occurred around the first half of habitual sleep. The fitted maximum advance and delay shifts were 1.8 h and 1.3 h, respectively. This new PRC will aid in determining the optimal time to administer exogenous melatonin to achieve desired phase shifts and demonstrates that using exogenous melatonin as a sleep aid at night has minimal phase shifting effects.

A three pulse phase response curve to three milligrams of melatonin in humans. Publishing Authors By Initials

HJ Burgess,VL Revell,CI Eastman,HJ Burgess,VL Revell,CI Eastman,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

A three pulse phase response curve to three milligrams of melatonin in humans. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: The Journal of physiology

VOLUME: 586

Page Numbers: 639-47

Journal Abbreviation: J. Physiol. (Lond.)

ISSN: 0022-3751

DAY: 15

MONTH: 11

YEAR: 2007

A three pulse phase response curve to three milligrams of melatonin in humans. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 266262

A three pulse phase response curve to three milligrams of melatonin in humans. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: A three pulse phase response curve to three milligrams of melatonin in humans. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for A three pulse phase response curve to three milligrams of melatonin in humans.

AFFILIATION: Biological Rhythms Research Laboratory, Rush University Medical Center, 1645 W. Jackson Blvd, Suite 425, Chicago, IL 60612, USA. helen_j_burgess@rush.edu.

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Physiol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

A three pulse phase response curve to three milligrams of melatonin in humans Related Publications

• A compromise phase position for permanent night shift workers: circadian phase after two night shifts with scheduled sleep and light/dark exposure.
• A proposal for the mechanism-of-action of diazoparaquinone natural products.
• A three pulse phase response curve to three milligrams of melatonin in humans.
• Can even minimal news coverage influence consumer health-related behaviour? A case study of iodized salt sales, Australia.
• Changing patterns of bacterial infection.
• DNA damage-induced S phase arrest in human breast cancer depends on Chk1, but G2 arrest can occur independently of Chk1, Chk2 or MAPKAPK2.
• Defective p53 signaling in p53 wild-type tumors attenuates p21waf1 induction and cyclin B repression rendering them sensitive to Chk1 inhibitors that abrogate DNA damage-induced S and G2 arrest.
• Deoxyribonuclease II in apoptosis and the significance of intracellular acidification.
• Dispatch from Landstuhl.
• Fork it over: the cohesion establishment factor Ctf7p and DNA replication.
• Further observations on the suppository as a contraceptive.
• Human tau in an ultradian light-dark cycle.
• Infant Mortality in Relation to Month of Birth.
• Information fluency for undergraduate biology majors: applications of inquiry-based learning in a Developmental Biology course.
• Long-loop reflexes in the tranquilized monkey.
• Lumbar ganglionectomy in peripheral arteriosclerosis.
• Modulation of cell cycle progression in human tumors: a pharmacokinetic and tumor molecular pharmacodynamic study of cisplatin plus the Chk1 inhibitor UCN-01 (NSC 638850).
• Niche differentiation among sulfur-oxidizing bacterial populations in cave waters.
• Nutrition in Relation to Pregnancy and Lactation.
• Obstruction of the common duct by stone.
• Pelvic mensuration; a study in the perpetuation of error.
• Phylogenetic Footprinting Analysis in the Upstream Regulatory Regions of the Drosophila Enhancer of split Genes.
• Problems in the evolution of obstetrics.
• Prolactin and the return of ovulation in breast-feeding women.
• Role of chromosome segregation genes in BRCA1-dependent lethality.
• Studies on the mechanism of action of prekinamycin, a member of the diazoparaquinone family of natural products: evidence for both sp2 radical and orthoquinonemethide intermediates.
• The Future of Emergency Care in the United States Health System: an Institute of Medicine report.
• The plasma proteins--recent biochemical advances.
• The plasma proteins-clinical applications.
• p53-based cancer therapies: Is defective p53 the Achilles heel of the tumor?